Targanta appoints two new board members
This article was originally published in Scrip
Targanta Therapeutics (US) has appointed Stéphane Bancel and Rosemary Crane to its board of directors. Mr Bancel is CEO for bioMérieux, while Ms Crane most recently served as company group chairman of Johnson & Johnson's OTC/nutritionals business. The appointments bring the total number of Targanta board directors to eight.